I know, hence it will help formulate part of MSB's argument about why they cannot conduct a RCT, since it will be unethical. But if you remember, the FDA still recommended a RCT as part of the CRL in spite of what was argued as part of ODAC.
And as Lopez mentioned, the FDA also requested a lot of data, which will help MSB's attempt to bypass the need for a RCT. So in the end it will come down to whether the FDA will require a RCT or whether MSB have done enough to bypass this requirement.
Or are you saying that an RCT is irrelevant?
- Forums
- ASX - By Stock
- Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
I know, hence it will help formulate part of MSB's argument...
-
- There are more pages in this discussion • 858 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.02 |
Change
0.015(1.49%) |
Mkt cap ! $1.164B |
Open | High | Low | Value | Volume |
$1.00 | $1.04 | 94.0¢ | $11.76M | 11.90M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 206912 | $1.02 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.03 | 37637 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 206912 | 1.015 |
8 | 195410 | 1.010 |
5 | 95607 | 1.005 |
7 | 208096 | 1.000 |
3 | 103747 | 0.995 |
Price($) | Vol. | No. |
---|---|---|
1.025 | 37637 | 1 |
1.030 | 29757 | 2 |
1.035 | 91225 | 3 |
1.040 | 72457 | 5 |
1.045 | 126212 | 4 |
Last trade - 16.10pm 31/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, CEO
Anthony Noble
CEO
SPONSORED BY The Market Online